다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Harmony Biosciences Holdings Inc (HRMY)
Harmony Biosciences Holdings Inc (HRMY) 뉴스

HRMY

Harmony Biosciences (HRMY)

Harmony Biosciences Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HRMY

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/31	21:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/05/31	21:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/05/30	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/05/28	21:05	PR Newswire (US)	HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/04/30	20:05	GlobeNewswire Inc.	Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/04/30	20:00	PR Newswire (US)	Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/04/16	21:05	PR Newswire (US)	HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/04/11	21:05	PR Newswire (US)	HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/04/03	21:05	PR Newswire (US)	HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/03/26	21:05	PR Newswire (US)	HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/03/12	06:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/03/09	06:21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/29	07:16	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/28	22:05	PR Newswire (US)	HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/23	06:14	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/22	22:00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/22	22:00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/22	21:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/22	21:30	GlobeNewswire Inc.	Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/21	22:05	PR Newswire (US)	U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/20	22:05	PR Newswire (US)	HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/14	09:06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/02/08	22:05	PR Newswire (US)	HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/01/27	06:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/01/27	06:58	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/01/27	06:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/01/27	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/01/08	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/01/08	22:05	PR Newswire (US)	HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE	NASDAQ:HRMY	Harmony Biosciences Holdings Inc
2024/01/03	22:05	PR Newswire (US)	HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE	NASDAQ:HRMY	Harmony Biosciences Holdings Inc

검색 관련기사 보기:NASDAQ:HRMY

1 2 3 4 5 6 7 8 9 10 다음 >>

Invesco QQQ Trust Series 1

Financial Select Sector

BNP Paribas (QX)

JP Morgan Chase

Health Care Select Sector

Bank of America

Deutsche Telekom (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관